Susan E Graf's Net Worth
$527 Thousand
Who is Susan E Graf?
Susan E Graf does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Finch Therapeutics Group, Inc., Epizyme, Inc., and NPS PHARMACEUTICALS INC.
SEC CIK
Susan E Graf's CIK is 0001577637
Past Insider Trading and Trends
2014 was Susan E Graf's most active year for acquiring shares with 3 total transactions. Susan E Graf's most active month to acquire stocks was the month of January. 2015 was Susan E Graf's most active year for disposing of shares, totalling 10 transactions. Susan E Graf's most active month to dispose stocks was the month of January. 2015 saw Susan E Graf paying a total of $99,993.90 for 19,061 shares, this is the most they've acquired in one year. In 2015 Susan E Graf cashed out on 98,650 shares for a total of $549,031.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Finch Therapeutics Group, Inc. (FNCH) Snapshot price: $2.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.01K |
$0.27 | $1,352.70 | 5.01K |
Jun 8 - Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Epizyme, Inc. No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NPS PHARMACEUTICALS INC No price found
VP,Corp Development & Strategy
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.76K |
$46.00 | -$219,006.00 |
0
|
Feb 21
| |||
Form 4
| +25.29% | 961 |
$45.85 | -$22,191.40 | 4.76K |
Feb 12
| |||
Form 4
|
—
|
0
|
$30.39 | -$207,840.34 | 3.8K |
Feb 10
| |||
Form 4
|
∞
| 3.8K |
$33.10 | -$65,802.80 | 3.8K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CG Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |